Skip to main content Accessibility help
×
Hostname: page-component-8448b6f56d-mp689 Total loading time: 0 Render date: 2024-04-25T04:20:03.697Z Has data issue: false hasContentIssue false

6 - Interface of care and communication

Published online by Cambridge University Press:  22 January 2010

Molly Courtenay
Affiliation:
University of Surrey
Matt Griffiths
Affiliation:
University of the West of England, Bristol
Get access

Summary

Objectives

  1. Identify the types of medication problems that arise at transition points in primary healthcare.

  2. Explore the reasons why these problems occur.

  3. Discuss possible methods of improving patient safety.

Summary

Interfaces and transitions relating to medicines use occur across healthcare settings and between healthcare professionals. This chapter focuses on primary care where the majority of medicines are prescribed and used. Medicines related problems (MRPs) have effects ranging from inconvenience, through impaired quality of life, to serious harm. There is increasing evidence that many MRPs are caused by communication failures and that future solutions need to include tackling the human causes of inadequate communication. Four medicines (anticoagulants, diuretics, non-steroidal anti-infl ammatories and antiplatelet medicines) are responsible for half of the medicines related hospital admissions and many of these episodes could be prevented with improved surveillance and interventions in primary care. Possible solutions are discussed including proactive monitoring in partnership with patients (including clinicians not making assumptions that someone else has ensured safety), the use of medicines review, and methods of strengthening patients' and carers' knowledge. All healthcare professionals should be vigilant and not assume that the correct prescription, supply, appropriateness and safety of medication has been checked already. Clinicians need to give adequate information to patients and check the patient' knowledge. All healthcare professionals should be vigilant and not assume that the correct prescription, supply, appropriateness and safety of medication has been checked already. Clinicians need to give adequate information to patients and check the patients or carer's knowledge at each stage. Patients should be regarded as experts in their own conditions and be encouraged to fl ag up any concerns.

Type
Chapter
Information
Medication Safety
An Essential Guide
, pp. 83 - 96
Publisher: Cambridge University Press
Print publication year: 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Avorn, J, Shrank, WH. (2008). Adverse drug reactions in elderly people: a substantial cause of preventable illness. British Medical Journal, 336, 956–7.CrossRefGoogle ScholarPubMed
Baglin, TP, Cousins, D, Keeling, DM, Perry, DJ, Watson, HG. (2006). Recommendations from the British Committee for Standards in Haematology and National Patient Safety Agency. British Journal of Haematology, 136, 26–9.CrossRefGoogle ScholarPubMed
Blenkinsopp, A, Celino, G, Bond, CM, Inch, J. (2007). Medicines Use Review: The first year of a new community pharmacy service. Pharm Journal, 278, 218–23.Google Scholar
Chen, YF, Neil, KE, Avery, AJ, Dewey, ME, Johnson, C. (2005). Prescribing errors and other problems reported by community pharmacists. Therapy Clinical Risk Management, 1(4), 333–42.Google ScholarPubMed
,Clinical Knowledge Service. Patient Leaflet. Anti-inflammatories non-steroidal. http://www.cks.library.nhs.uk/patient_information_leaflet/anti_inflammatories_non_steroidal (accessed 17/5/09).
Clyne, W, Blenkinsopp, A, Seal, R. (2008). A guide to medication review. NPC Plus with Medicines Partnership. http://www.npci.org.uk/medicines.management/review/medireview/library/librarygoodpracticeguide1.Php. Accessed 30/3/09.
Connelly, D. (2005). User testing of PILs now mandatory. Pharm J 2005; 275, 12.Google Scholar
Fraenkel, L, Wittink, D, Concato, J, Fried, T. (2004). Treatment options in knee osteoarthritis: the patient's perspective. Archives Intemat Medicine, 164, 1299–304.CrossRefGoogle ScholarPubMed
Gérardin-Marais, M, Victorri-Vigneau, C, Allain-Veyrac, G, et al. (2008). Diuretic drug therapy monitoring in the elderly: a cohort study. European Journal of Clinical Pharmacology, 64, 433–7.CrossRefGoogle ScholarPubMed
Hansen, LB, Fernald, D, Araya-Guerra, R, Westfall, JM, West, D, Pace, W. (2006). Pharmacy clarification of prescriptions ordered in primary care: a report from the Applied Strategies for Improving Patient Safety (ASIPS) collaborative. Journal of the American Board Family Medicine, 19(1), 24–30.CrossRefGoogle ScholarPubMed
Heneghan, C, Alonso-Coello, P, Garcia-Allemina, JM, Perera, R, Meats, E, Glasziou, P. (2006). Self-monitoring of oral anticoagulation: a systematic review and meta analysis. Lancet, 367, 404–11.CrossRefGoogle ScholarPubMed
Howard, R, Avery, A, Bissell, P. (2008) Causes of preventable drug-related hospital admissions: a qualitative study. Quality and Safety in Health Care, 17, 109–16.CrossRefGoogle ScholarPubMed
Howard, RL, Avery, AJ, Slavenburg, S, et al. (2007). Which drugs cause preventable admissions to hospital? A systematic review. British Journal of Clinical Pharmacology, 63(2), 136–47.CrossRefGoogle ScholarPubMed
Indermitte, J, Beutler, M, Bruppacher, R, Meier, CR, Hersberger, KE. (2007). Management of drug-interaction alerts in community pharmacies. Journal of Clinical Pharm Therapy, 32(2), 133–42.CrossRefGoogle ScholarPubMed
Jester, R. (2007). In: Advancing Practice in Rehabilitation Nursing. Blackwell Publishing (2007).CrossRefGoogle Scholar
Moberly, T. (2008). Community pharmacy plays its part in making anticoagulation safer. Pharm Journal, 280, 78.Google Scholar
,National Kidney Federation. Know Your Numbers. http://www.kidney.org.uk/Medical-Info/other/know_nos.html (accessed 28/4/08).
,National Patient Safety Agency. (2008). Anticoagulant therapy: information for community pharmacists.
Passare, G, Viitanen, M, Törring, O, Winblad, B, Fastbom, J. (2004). Sodium and potassium disturbances in the elderly: prevalence and association with drug use. Clinical Drug Investigation, 24(9), 535–44.CrossRefGoogle ScholarPubMed
Raynor, DK, Blenkinsopp, A, Knapp, P, et al. (2007). A systematic review of quantitative and qualitative research on the role and effectiveness of written information available to patients about individual medicines. Health Technol Assessment, (5):iii, 1–160. Review.Google Scholar
Sarahsohn-Kahn, J. (2008). The wisdom of patients. Healthcare meets online social media. California Health Foundation. http://www.chcf.org/documents/chronicdisease/HealthCareSocialMedia.pdf (accessed 28/4/08).
Schillinger, D, Wang, F, Rodriguez, M, Bindman, A, Machtinger, EL. (2006). The importance of establishing regimen concordance in preventing medication errors in anticoagulant care. Journal of Health Communications, 11(6), 555–67.CrossRefGoogle ScholarPubMed
Spinewine, A. (2008). The challenge of safer prescribing. British Medical Journal, 336, 956–7.CrossRefGoogle ScholarPubMed
Weingart, SN, Gandhi, TK, Seger, AC, et al. (2005). Patient-reported medication symptoms in primary care. Archives Intern Medicine, 165(2), 234–40.CrossRefGoogle ScholarPubMed
Weingart, SN, Hamrick, HE, Tutkus, S, et al. (2008). Medication safety messages for patients via the web portal: The MedCheck intervention. Int J Med Inform, 77(3), 161–8.CrossRefGoogle ScholarPubMed
Wilcox, CM, Cryer, B, Triadafilopoulos, G. (2005). Patterns of use and public perception of over-the-counter pain relievers: focus on nonsteroidal antiinflammatory drugs. Journal of Rheumatology, 32(11), 2218–24.Google ScholarPubMed
Witherington, EM, Pirzada, OM, Avery, AJ. (2008). Communication gaps and readmissions to hospital for patients aged 75 years and older: observational study. Quality Safety Health Care, 17(1), 71–5.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×